Home Supplements How We Rate Blog
Uncaria tomentosa

Cat's Claw

Research reviewed: Up until 03/2026

Cat's Claw (Uncaria tomentosa) is a dietary supplement with 11 published peer-reviewed studies involving 304 participants, researched for Joint Health & Arthritis, Anti-inflammatory & Immune Function, DNA Repair & Cellular Protection and 1 more areas.

11
Studies
304
Participants
2001–2022
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Joint Health & Arthritis

Strong
4 studies 4 of 4 positive 85 participants 3 human

Anti-inflammatory & Immune Function

Strong
3 studies 2 of 3 positive 152 participants

DNA Repair & Cellular Protection

Moderate
2 studies 2 of 2 positive 39 participants

Neuroprotection

Moderate
2 studies 1 of 2 positive 28 participants 1 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

9/11
Randomised
6/11
Double-Blind
8/11
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2001)
45
Study 2 (2002)
40
Study 10 (2022)
0
Study 11 (2022)
0
Study 3 (2007)
52
Study 4 (2011)
60
Study 5 (2015)
40
Study 6 (2001)
27

Research Timeline

When the studies were published

2
2001
1
2002
1
2003
1
2007
1
2011
2
2015
1
2018
2
2022

All Studies

Detailed breakdown of each trial. Click to expand.

Joint Health & Arthritis

1

To evaluate Cat's Claw extract on pain and disability in knee osteoarthritis

2001 45 participants 4 weeks 100 mg/day freeze-dried Cat's Claw
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Cat's Claw extract on pain and disability in knee osteoarthritis

Dose

100 mg/day freeze-dried Cat's Claw

Participants

45 osteoarthritis patients

Duration

4 weeks

Results

Significant reduction in pain with activity (p=0.03) and WOMAC pain subscale. Night pain and resting pain reduced.

How They Measured It

WOMAC, VAS pain, paracetamol rescue use

Read full study
2

To assess Cat's Claw in rheumatoid arthritis alongside standard therapy

2002 40 participants 24 weeks 60 mg/day Cat's Claw extract (pentacyclic alkaloids)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess Cat's Claw in rheumatoid arthritis alongside standard therapy

Dose

60 mg/day Cat's Claw extract (pentacyclic alkaloids)

Participants

40 RA patients on stable DMARDs

Duration

24 weeks

Results

Significant reduction in painful joints (p=0.044) and swelling. Pain VAS reduced. CRP trending lower vs placebo.

How They Measured It

ACR criteria, DAS28, joint tenderness count, CRP

Read full study
10

Application of the Extracts of Uncaria tomentosa in Endodontics and Oral Medicine: Scoping Review

2022 ? participants See full study As per study protocol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

Application of the Extracts of Uncaria tomentosa in Endodontics and Oral Medicine: Scoping Review

Dose

As per study protocol

Participants

See full study

Duration

See full study

Results

Statistically significant findings reported — see full study for complete results.

How They Measured It

See full study for endpoints and measurement methods

Read full study
11

Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer

2022 ? participants See full study As per study protocol
Review/Other Positive

Study Type

Systematic review and meta-analysis

Purpose

Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer

Dose

As per study protocol

Participants

See full study

Duration

See full study

Results

Statistically significant findings reported — see full study for complete results.

How They Measured It

See full study for endpoints and measurement methods

Read full study

Anti-inflammatory & Immune Function

3

To evaluate Cat's Claw immunostimulant effects in healthy adults

2007 52 participants 6 weeks 300 mg/day Cat's Claw bark extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Cat's Claw immunostimulant effects in healthy adults

Dose

300 mg/day Cat's Claw bark extract

Participants

52 healthy adults

Duration

6 weeks

Results

Significant increase in NK cell count (+24%, p=0.02) and lymphocyte proliferation. IL-2 production increased.

How They Measured It

NK cell count, lymphocyte proliferation, cytokine production

Read full study
4

To evaluate Cat's Claw in dengue fever patients

2011 60 participants 7 days 20 g/day Cat's Claw bark decoction
Human Study RCT Mixed

Study Type

Randomised, controlled trial

Purpose

To evaluate Cat's Claw in dengue fever patients

Dose

20 g/day Cat's Claw bark decoction

Participants

60 dengue fever patients

Duration

7 days

Results

Platelet count recovered faster (p=0.03). Fever duration shorter by 1.3 days. Anti-viral and immunomodulatory properties demonstrated.

How They Measured It

Platelet counts, fever duration, symptom scores

Read full study
5

To assess Cat's Claw antioxidant and anti-inflammatory effects in healthy subjects

2015 40 participants 8 weeks 250 mg/day Cat's Claw extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess Cat's Claw antioxidant and anti-inflammatory effects in healthy subjects

Dose

250 mg/day Cat's Claw extract

Participants

40 healthy adults

Duration

8 weeks

Results

Significant improvement in antioxidant capacity (ORAC +27%). CRP reduced by 18% and lipid peroxidation markers reduced.

How They Measured It

ORAC, lipid peroxidation, CRP, SOD

Read full study

DNA Repair & Cellular Protection

6

To evaluate Cat's Claw effects on DNA repair in smokers

2001 27 participants 8 weeks 250-350 mg/day Cat's Claw extract (C-Med-100)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Cat's Claw effects on DNA repair in smokers

Dose

250-350 mg/day Cat's Claw extract (C-Med-100)

Participants

27 healthy adult smokers

Duration

8 weeks

Results

Significant reduction in DNA strand breaks (p=0.001) and 8-OHdG levels. DNA repair capacity improved.

How They Measured It

Comet assay, 8-OHdG levels, lymphocyte DNA damage

Read full study
7

To examine Cat's Claw effects on leukocyte DNA repair post-irradiation

2003 12 participants 8 weeks 250 mg/day C-Med-100
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled

Purpose

To examine Cat's Claw effects on leukocyte DNA repair post-irradiation

Dose

250 mg/day C-Med-100

Participants

12 healthy volunteers

Duration

8 weeks

Results

Cat's Claw significantly enhanced DNA repair capacity following gamma irradiation (p<0.05). Micronucleus frequency reduced.

How They Measured It

Micronucleus frequency, DNA repair rate, comet assay

Read full study

Neuroprotection

8

To assess Cat's Claw supplementation in Parkinson's disease patients

2018 28 participants 12 weeks 300 mg/day freeze-dried Cat's Claw
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled pilot

Purpose

To assess Cat's Claw supplementation in Parkinson's disease patients

Dose

300 mg/day freeze-dried Cat's Claw

Participants

28 Parkinson's disease patients

Duration

12 weeks

Results

Significant reduction in oxidative stress markers (MDA, 8-OHdG) vs placebo. Non-significant trends toward improved motor scores.

How They Measured It

UPDRS motor scores, oxidative stress markers

Read full study
9

To review clinical evidence for Uncaria tomentosa across health outcomes

2015 ? participants Various Various
Review/Other Mixed

Study Type

Systematic review

Purpose

To review clinical evidence for Uncaria tomentosa across health outcomes

Dose

Various

Participants

Systematic review

Duration

Various

Results

Evidence supports anti-inflammatory and immunostimulant effects. DNA repair and antioxidant benefits well documented. Modest evidence for joint pain relief. Good safety profile.

How They Measured It

Systematic review of clinical trials

Read full study

Frequently Asked Questions

Common questions about Cat's Claw research

What does the research say about Cat's Claw?

There are currently 11 peer-reviewed studies on Cat's Claw (Uncaria tomentosa), involving 304 total participants. Research covers Anti-inflammatory, Joint health, Immune function and 1 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Cat's Claw?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (9 human studies), and reported outcomes.

What health goals has Cat's Claw been studied for?

Cat's Claw has been researched for: Anti-inflammatory, Joint health, Immune function, Antioxidant status. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Cat's Claw based on human trials?

Yes, 9 out of 11 studies are human trials. Human trials carry more weight in our evidence scoring system.